In a K-Ras-activated autochthonous mouse model of NSCLC, synthetic let-7b mimics conjugated with neural lipid emulsions (NLE) was systemically delivered to lung via intravenous administration, leading to reduced tumor burden [146]. This evidence concerns the gene KRAS and neoplasm.